• 1
    Dhote R,Pellicer-Coeuret M,Thiounn N,Debre B,Vidal-Trecan G. Risk factors for adult renal cell carcinoma: a systematic review and implications for prevention. BJU Int 2000; 86: 207.
  • 2
    Pantuck AJ,Zisman A,Belldegrun AS. The changing natural history of renal cell carcinoma. J Urol 2001; 166: 161123.
  • 3
    Canfield SE,Kamat AM,Sanchez-Ortiz RF,Detry M,Swanson DA,Wood CG. Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease (clinical stage TxN1-2M0): the impact of aggressive surgical resection on patient outcome. J Urol 2006; 175: 8649.
  • 4
    Rafla S. Renal cell carcinoma. Natural history and results of treatment. Cancer 1970; 25: 2640.
  • 5
    Skinner DG,Colvin RB,Vermillion CD,Pfister RC,Leadbetter WF. Diagnosis and management of renal cell carcinoma. A clinical and pathologic study of 309 cases. Cancer 1971; 28: 116577.
  • 6
    Giuliani L,Giberti C,Martorana G,Rovida S. Radical extensive surgery for renal cell carcinoma: long-term results and prognostic factors. J Urol 1990; 143: 46873.
  • 7
    Pantuck AJ,Zisman A,Dorey F,Chao DH,Han KR,Said J,Gitlitz BJ,Figlin RA,Belldegrun AS. Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection. J Urol 2003; 169: 207683.
  • 8
    Johnsen JA,Hellsten S. Lymphatogenous spread of renal cell carcinoma: an autopsy study. J Urol 1997; 157: 4503.
  • 9
    Karakiewicz PI,Trinh QD,Bhojani N,Bensalah K,Salomon L,de la Taille A,Tostain J,Cindolo L,Altieri V,Ficarra V,Schips L,Zigeuner R, et al. Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease: prognostic indicators of disease-specific survival. Eur Urol 2007; 51: 161624.
  • 10
    Patard JJ,Leray E,Rodriguez A,Rioux-Leclercq N,Guille F,Lobel B. Correlation between symptom graduation, tumor characteristics and survival in renal cell carcinoma. Eur Urol 2003; 44: 22632.
  • 11
    Karakiewicz P,Perrotte P,Trinh QD,Patard JJ. Rebuttal from Authors Re: Edward M. Messing. Node positive renal cell cancer. Who can be helped? Eur Urol 2007; 51: 147880.
  • 12
    Briganti A,Chun FK,Salonia A,Zanni G,Scattoni V,Valiquette L,Rigatti P,Montorsi F,Karakiewicz PI. Validation of a nomogram predicting the probability of lymph node invasion among patients undergoing radical prostatectomy and an extended pelvic lymphadenectomy. Eur Urol 2006; 49: 101927.
  • 13
    Karakiewicz PI,Shariat SF,Palapattu GS,Perrotte P,Lotan Y,Rogers CG,Amiel GE,Vazina A,Gupta A,Bastian PJ,Sagalowsky AI,Schoenberg M, et al. Precystectomy nomogram for prediction of advanced bladder cancer stage. Eur Urol 2006; 50: 125460.
  • 14
    Patard JJ,Rioux-Leclercq N,Fergelot P. Understanding the importance of smart drugs in renal cell carcinoma. Eur Urol 2006; 49: 63343.
  • 15
    Blom JH,van Poppel H,Marechal JM,Jacqmin D,Sylvester R,Schroder FH,de Prijck L, Members of the EORTC Genitourinary Group. Radical nephrectomy with and without lymph node dissection: preliminary results of the EORTC randomized phase III protocol 30881. Eur Urol 1999; 36: 5705.
  • 16
    Ward JF,Blute ML,Cheville JC,Lohse CM,Weaver AL,Zincke H. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma. J Urol 2002; 168: 5660.
  • 17
    Dimashkieh HH,Lohse CM,Blute ML,Kwon ED,Leibovich BC,Cheville JC. Extranodal extension in regional lymph nodes is associated with outcome in patients with renal cell carcinoma. J Urol 2006; 176: 197882.